Related references
Note: Only part of the references are listed.Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
Michael D. Kappelman et al.
GASTROENTEROLOGY (2021)
COVID-19 Vaccination Is Safe and Effective in Patients With Inflammatory Bowel Disease: Analysis of a Large Multi-institutional Research Network in the United States
Yousaf Bashir Hadi et al.
GASTROENTEROLOGY (2021)
Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan
Kazuo Imai et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp et al.
NATURE (2021)
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Nicholas A. Kennedy et al.
GUT (2021)
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
David Hodgson et al.
EUROSURVEILLANCE (2021)
Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications
Nabeel Khan et al.
GASTROENTEROLOGY (2021)
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission
Patrick J. Lillie et al.
JOURNAL OF INFECTION (2020)
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Victoria A. Avanzato et al.
CELL (2020)
Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy
Perry K. Pratt et al.
INFLAMMATORY BOWEL DISEASES (2018)
Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
Jin Kyun Park et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
Niels Vande Casteele et al.
GUT (2015)
Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Anti-TNF treatment blocks the induction of T cell-dependent humoral responses
Gabriela Franco Salinas et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays
N. Vande Casteele et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Immunosuppression Impairs Response to Pneumococcal Polysaccharide Vaccination in Patients With Inflammatory Bowel Disease
Gil Y. Melmed et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
Ori Elkayam et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-α reveals an essential role for TNF
U Ritter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Share Paper
